BIO Financial Facts
Gross profit: 280.23MSelling, general and administrative expense: 205.54M
See Full Income Statement
Property, plant and equipment, net: 457.69M
Other assets: 64.78M
See Full Balance Sheet
Bio-Rad Laboratories, Inc. (BIO) Earnings
|
Expand Research on BIO
| Next EPS Date | 10/22/26 | EPS Growth Rate | +5.3% |
|---|---|---|---|
| Average EPS % Beat Rate | +14.0% | Revenue Growth Rate | -0.3% |
| Average % Move 1-Wk after EPS | -4.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/22/26  |
Q326 | N/A | $2.38 | N/A | N/A | $651.15M | N/A | N/A | N/A | ||
| 8/4/26 |
Q226 | $2.62 | $1.81 | +$0.81 | $651M | $623.89M | N/A |  | | Details | |
| 4/30/26 | Q126 | $1.89 | $1.84 | +$0.05 | $592.1M | $586.97M | N/A | | | Details | |
| 2/12/26 | Q425 | $2.51 | $2.71 | -$0.20 | $693.2M | $692.96M | N/A | | | Details | |
| 10/29/25 | Q325 | $2.26 | $1.95 | +$0.31 | $653M | $652.24M | N/A | | | Details | |
| 7/31/25 | Q225 | $2.61 | $1.73 | +$0.88 | $651.6M | $615.2M | N/A | | | Details | |
| 5/1/25 | Q125 | $2.54 | $1.80 | +$0.74 | $585.4M | $573.22M | N/A | | | Details | |
| 2/13/25 | Q424 | $2.90 | $2.86 | +$0.04 | $667.5M | $681.29M | N/A | | | Details |
